↓ Skip to main content

JIMD Reports, Volume 38

Overview of attention for book
Cover of 'JIMD Reports, Volume 38'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 19 First Successful Conception Induced by a Male Cystinosis Patient
  3. Altmetric Badge
    Chapter 21 Treatment of Depression in Adults with Fabry Disease
  4. Altmetric Badge
    Chapter 24 Successful Management of Pregnancies in Patients with Inherited Disorders of Ketone Body Metabolism
  5. Altmetric Badge
    Chapter 25 Mutations in GMPPB Presenting with Pseudometabolic Myopathy
  6. Altmetric Badge
    Chapter 26 Glutaric Acidemia Type 1: A Case of Infantile Stroke.
  7. Altmetric Badge
    Chapter 27 Heterogeneous Phenotypes in Lipid Storage Myopathy Due to ETFDH Gene Mutations
  8. Altmetric Badge
    Chapter 28 Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry
  9. Altmetric Badge
    Chapter 29 Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1
  10. Altmetric Badge
    Chapter 30 Ketone Bodies as a Possible Adjuvant to Ketogenic Diet in PDHc Deficiency but Not in GLUT1 Deficiency
  11. Altmetric Badge
    Chapter 31 GM2 Activator Deficiency Caused by a Homozygous Exon 2 Deletion in GM2A
  12. Altmetric Badge
    Chapter 32 Effect of Lorenzo’s Oil on Hepatic Gene Expression and the Serum Fatty Acid Level in abcd1- Deficient Mice
  13. Altmetric Badge
    Chapter 33 Introduction of a Simple Second Tier Screening Test for C5 Isobars in Dried Blood Spots: Reducing the False Positive Rate for Isovaleric Acidaemia in Expanded Newborn Screening
  14. Altmetric Badge
    Chapter 34 A Rapid Two-Step Iduronate-2-Sulfatatse Enzymatic Activity Assay for MPSII Pharmacokinetic Assessment
  15. Altmetric Badge
    Chapter 35 An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia
  16. Altmetric Badge
    Chapter 37 Peripheral Neuropathy, Episodic Rhabdomyolysis, and Hypoparathyroidism in a Patient with Mitochondrial Trifunctional Protein Deficiency
Attention for Chapter 30: Ketone Bodies as a Possible Adjuvant to Ketogenic Diet in PDHc Deficiency but Not in GLUT1 Deficiency
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Ketone Bodies as a Possible Adjuvant to Ketogenic Diet in PDHc Deficiency but Not in GLUT1 Deficiency
Chapter number 30
Book title
JIMD Reports, Volume 38
Published in
JIMD Reports, May 2017
DOI 10.1007/8904_2017_30
Pubmed ID
Book ISBNs
978-3-66-256609-1, 978-3-66-256610-7
Authors

Habarou, F., Bahi-Buisson, N., Lebigot, E., Pontoizeau, C., Abi-Warde, M. T., Brassier, A., Le Quan Sang, K. H., Broissand, C., Vuillaumier-Barrot, S., Roubertie, A., Boutron, A., Ottolenghi, C., de Lonlay, P., F. Habarou, N. Bahi-Buisson, E. Lebigot, C. Pontoizeau, M. T. Abi-Warde, A. Brassier, K. H. Le Quan Sang, C. Broissand, S. Vuillaumier-Barrot, A. Roubertie, A. Boutron, C. Ottolenghi, P. de Lonlay

Abstract

Ketogenic diet is the first line therapy for neurological symptoms associated with pyruvate dehydrogenase deficiency (PDHD) and intractable seizures in a number of disorders, including GLUT1 deficiency syndrome (GLUT1-DS). Because high-fat diet raises serious compliance issues, we investigated if oral L,D-3-hydroxybutyrate administration could be as effective as ketogenic diet in PDHD and GLUT1-DS. We designed a partial or total progressive substitution of KD with L,D-3-hydroxybutyrate in three GLUT1-DS and two PDHD patients. In GLUT1-DS patients, we observed clinical deterioration including increased frequency of seizures and myoclonus. In parallel, ketone bodies in CSF decreased after introducing 3-hydroxybutyrate. By contrast, two patients with PDHD showed clinical improvement as dystonic crises and fatigability decreased under basal metabolic conditions. In one of the two PDHD children, 3-hydroxybutyrate has largely replaced the ketogenic diet, with the latter that is mostly resumed only during febrile illness. Positive direct effects on energy metabolism in PDHD patients were suggested by negative correlation between ketonemia and lactatemia (r (2) = 0.59). Moreover, in cultured PDHc-deficient fibroblasts, the increase of CO2 production after (14)C-labeled 3-hydroxybutyrate supplementation was consistent with improved Krebs cycle activity. However, except in one patient, ketonemia tended to be lower with 3-hydroxybutyrate administration compared to ketogenic diet. 3-hydroxybutyrate may be an adjuvant treatment to ketogenic diet in PDHD but not in GLUT1-DS under basal metabolic conditions. Nevertheless, ketogenic diet is still necessary in PDHD patients during febrile illness.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 29%
Student > Master 4 29%
Student > Bachelor 1 7%
Other 1 7%
Student > Ph. D. Student 1 7%
Other 0 0%
Unknown 3 21%
Readers by discipline Count As %
Medicine and Dentistry 4 29%
Neuroscience 2 14%
Nursing and Health Professions 2 14%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Agricultural and Biological Sciences 1 7%
Other 1 7%
Unknown 3 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2017.
All research outputs
#15,104,977
of 23,245,494 outputs
Outputs from JIMD Reports
#322
of 560 outputs
Outputs of similar age
#187,125
of 314,230 outputs
Outputs of similar age from JIMD Reports
#3
of 8 outputs
Altmetric has tracked 23,245,494 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 560 research outputs from this source. They receive a mean Attention Score of 2.8. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,230 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.